Difficult asthma is a heterogeneous disease of the airways including various types of bronchial inflammation and various degrees of airway remodeling. Therapeutic response of severe asthmatics can be predicted by the use of biomarkers of Type2-high or Type2-low inflammation. Based on sputum cell analysis, four inflammatory phenotypes have been described. As induced sputum is timeconsuming and e...

Background The advent of a series of novel serum and urinary biomarkers has prompted research into their efficacy as diagnostic and prognostic tools. They hold potential as alternatives to current clinical use of serum creatinine as a marker of impaired renal function and damage. While the predictive value of biomarkers is being studied in a range of settings, a particular area of focus has bee...

Perhaps the greatest barrier to translation of serum biomarker discoveries is the inability to evaluate putative biomarkers in high throughput validation studies. Here we report on the development, production, and implementation of a high-density antibody microarray used to evaluate large numbers of candidate ovarian cancer serum biomarkers. The platform was shown to be useful for evaluation of...

BACKGROUND Identification of serum and bronchoalveolar lavage fluid (BALF) biomarkers may facilitate diagnosis and prognostication in various lung disorders. OBJECTIVE Serum and BALF levels of surfactant protein A (SP-A), surfactant protein D (SP-D), Clara cell protein 16 (CC16), S100 protein, trefoil factor 3 (TFF3), and prostatic secretory protein 94 (PSP94) were evaluated in 94 consecutive...

BACKGROUND Serum biomarkers may identify people at risk for cardiovascular (CV) outcomes. Biobanked serum samples from 8494 participants with dysglycemia in the completed Outcome Reduction With Initial Glargine Intervention trial were assayed for 284 biomarkers to identify those that could identify people at risk for a CV outcome or death when added to clinical measurements. METHODS AND RESUL...

pathological changes within an organ can be reflected as proteomic patterns in biological fluids such as plasma, serum, and urine. the surface-enhanced laser desorption and ionization time-of-flight mass spectrometry (seldi-tof ms) has been used to generate proteomic profiles from biological fluids. mass spectrometry yields redundant noisy data that the most data points are irrelevant features ...